← All candidates
5 insider filings on record.
14 filings on record.
ELTXElicio Therapeutics, Inc.
NasdaqCM · Healthcare · $49.93M
$1.99
-0.50% · Sep 15
5 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · dailyNo open-market activity in range
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
Reverse-split 1×. When a company does a reverse split, the chart rewrites its old prices to look far bigger than they really were — so the high early prices here aren't what ELTX ever actually traded at. The drop is real, but those huge old numbers aren't.
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$49.93M
Float
19.2M
73% public
Short % float
Pro
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
1 filingnewest first
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
Context
Wall St
$20.00 avg target
+905.0% vs today · 3 analysts
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
1 of 4 quarters beat
Q1 '26−$0.65 act−$0.18
Q4 '25−$0.49 act−$0.04
Q3 '25−$0.60 act−$0.12
Q2 '25−$0.66 act+$0.03
Coverage
Another Blow For ELTX? Elicio Raises Fresh Capital Weeks After Trial DisappointmentStocktwits · 07-02ELTX Stock Heads For Worst Day Ever — Elicio Therapeutics' Pancreatic Cancer Data DisappointsStocktwits · 06-15Wall Street Set to Open Higher in Thursday Trading; US Adds Only 57,000 Jobs in JuneMT Newswires · 07-02This Monthly Dividend Powerhouse Is Trading at a Bargain-Bin ValuationBarchart · 06-16
The file stays open
14 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice